Webinar #18 – Face Blindness
Dr. Ed Park of Recharge Biomedical explains face blindness, or prosopagnosia, which affects about one in fifty people. A case of significant improvement after exosome treatment is presented. (n.b. Exosomes are not FDA-approved to treat face blindness)
Edward Park, MD
02/04/2021
2 Comments
